Lasa Supergenerics Ltd Share Price

Pharmaceuticals - Indian - Bulk Drugs & Formln M/SNSE
—
As on 21 Nov 2026 at 03:01

LASA Price Chart

Market Cap
₹21.69 Cr
PE Ratio
—
ROCE
-20.67%

Lasa Supergenerics Ltd Performance

Lasa Supergenerics Ltd Fundamentals

Know More
Market Cap₹21.69 Cr
ROE-27.46%
P/E Ratio (TTM)—
EPS (TTM)—
P/B Ratio0.49
Dividend Yield0.00%
Industry P/E91.72
Book Value₹8.82
Debt to Equity0.22
Face Value₹10

Lasa Supergenerics Ltd Shareholding Pattern

Know More
Promoter53.6%
Foreign Institutions0%
Mutual Funds0%
Domestic Institutions0%
Public46.4%

Lasa Supergenerics Ltd Financial Statements

Know More
No data for this view.

Lasa Supergenerics Ltd Peer Comparison

Know More
StocksLTP(₹)Market Cap(Cr)52 Week Low-High(₹)
Sun Pharmaceutical Industries Ltd
₹1,885.10
-14.90(-0.78%)
4,52,298.61,583.7 - 2,046.9
Torrent Pharmaceuticals Ltd
₹4,698.80
87.80(+1.90%)
1,78,727.33,672.3 - 5,250.0
Dr Reddys Laboratories Ltd
₹1,390.50
-10.40(-0.74%)
1,16,144.51,101.0 - 1,414.9
Cipla Ltd
₹1,414.95
-3.55(-0.25%)
1,14,312.11,165.7 - 1,539.7
Lupin Ltd
₹2,010.00
11.20(+0.56%)
91,915.91,892.9 - 2,529.5

About Lasa Supergenerics

Lasa Supergenerics Limited was incorporated on March 11, 2016. The Company is primarily engaged in the business of manufacturing, trading, producing, processing, preparing, treating chemicals, API, Pharmaceuticals, drugs, etc. The Company is a vertically integrated group spanning the entire veterinary, animal and human healthcare value chain-from discovery-to-delivery, with established credentials in research, manufacturing and global marketing. The Company is a veterinary API manufacturing entity, which was acquired in April, 2012. The manufacturing facility is located at Mahad & Chiplun, in the Konkan region of Maharashtra. The Company launched two new block buster products with all-time strong segment, Oxycozanide. Oxyclozanide is an anthelmintic, used in the treatment and control of fascioliasis a topical worm infection in ruminants mainly domestic animals such as cattle, especially buffalos in farm, sheep, and goats. For this, the Company is setting up capacity in a brown field expansion at its Chiplun unit with a total capacity of 20 MT. It got huge demand all over the globe as it is manufactured and have strong entry barriers. The Scheme of Amalgamation of Harishree Aromatics and Chemicals Private Limited with the Company and their respective shareholders was approved by Hon'ble National Company Law Tribunal on December 23, 2022 which became effective from January 04, 2023 in year 2022-23. Following the said Scheme of Amalgamation, 1000 Equity Shares of Rs 10/- per share of the Company was allotted for every 35 Equity Shares of Rs 10/- of Harishree Aromatics and Chemicals Private Limited on January 5, 2023.

Parent Organisation—
Founded2016
Managing DirectorOmkar P Herlekar
NSE SymbolLASA

Lasa Supergenerics Ltd Resistance and Support levels

Resistance / Support data unavailable.

Lasa Supergenerics Ltd Technicals

Current Price
—
Bearish
0
Bullish
0
  • 20 Day—
  • 50 Day—
  • 100 Day—
  • 200 Day—

Lasa Supergenerics Ltd Latest News

View More
18 NOV 2026 | Wednesday
Lasa Supergenerics reported regulatory compliance details to Indian stock exchanges
19 OCT 2026 | Monday
Lasa Supergenerics reported regulatory compliance details to Indian stock exchanges
26 AUG 2026 | Wednesday
LASA Supergenerics appoints Janardan Kamlu Savala as Executive Director, pending shareholder approval

2026

Quarterly ResultRelease dateCheck Latest financial
Board MeetingAnnounced
Quarterly ResultRelease dateCheck Latest financial
Quarterly ResultRelease dateCheck Latest financial
Quarterly ResultRelease dateCheck Latest financial
Board MeetingAnnounced

Frequently asked questions

The P/B ratio of Lasa Supergenerics Ltd is 0.49 as of 21 Nov 2026 at 03:01.

Not sure where to start?

Book a free 30-minute consultation with our investment experts today!

Invest Now